Your session is about to expire
← Back to Search
Stellate Ganglion Block for Post-Traumatic Stress Disorder
Study Summary
This trial will enroll people with PTSD and use fMRI to study brain function before and after they receive a treatment or placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with bipolar I disorder and had a manic episode in the past year.I have had a stellate ganglion block procedure.I have COPD or asthma that hasn't been treated.I have issues with my vocal cords or paralysis.I am currently undergoing therapy for trauma.I have a history of brain-related diseases, seizures, or major head injuries.I am between 18 and 65 years old.I am currently diagnosed with cancer.I have had surgery on my neck or throat.I have been diagnosed with Parkinson's Disease.My BMI is over 40.My medications have been the same for the last 3 months, except for benzodiazepines.I have been diagnosed with Guillain-Barré syndrome.I have been diagnosed with a psychotic disorder or have had psychotic symptoms.I have had heavy metal poisoning in the past.I have high blood pressure that hasn't been treated.I have heart conditions or have had heart surgery.I have had PTSD symptoms for over a month.I am between 18 and 65 years old.
- Group 1: Control Group
- Group 2: Stellate Ganglion Block (SGB) Group
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Federal Drug Administration (FDA) sanctioned Bupivacaine for public use?
"Based on the Phase 4 categorization, Bupivacaine is accepted to be safe and thus received a rating of 3."
Who is qualified to participate in this clinical trial?
"Participants must meet two criteria to be accepted into this clinical study. They should have PTSD and reside within the age range of 18-65 years old. As for numbers, 127 individuals are needed in total."
What is the fundamental objective of this medical investigation?
"This clinical trial will be monitored over a period of two weeks and eight weeks, with the principal aim being to measure changes in cerebral blood flow levels. Secondary objectives include ascertaining participants' state-trait anxiety inventory (STAI) - Form Y1 scores; patient health questionnaire-9 (PHQ-9) scores; and intolerance of uncertainty scale - short form (IUS-12) scores."
Is this medical study enrolling individuals aged 50 and above?
"This medical trial is open to those aged 18-65. There are 46 trials specifically targeting minors and 329 studies for seniors."
Is there still capacity for enrollees in this clinical study?
"Affirmative. According to the clinicaltrials.gov database, this medical trial is currently recruiting patients. It was first advertised on June 27th 2022 and has since been updated for accuracy. The study requires 127 participants from a single site of recruitment."
How many people have registered for the medical trial to date?
"Affirmative. According to information on clinicaltrials.gov, this research endeavour is currently recruiting participants; the trial was initially posted and last edited on 6/27/2022. The study aims to enlist 127 individuals from one site in total."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger